Nonprofit seeks to widen access to CAR-T cell therapy

The deals will initially involve manufacturing therapies for combating lymphoma and leukemia in Brazil and India. 

May 10, 2024 Check out STAT+

Sponsored By

Adobe STAT+ | A nonprofit does deals in Brazil and India to make low-cost CAR-T cell therapies widely available "We're trying to crack this nut of affordability and accessibility," said Boro Dropulić, who heads the Caring Cross nonprofit. By Ed Silverman Exact Sciences' stock tumbles amid worries cancer detection firm's growth may slow Will colon cancer screening revenue increase steeply enough to meet the cancer detection company's projections? By Jonathan Wosen Q&A with Jennifer Adair, researcher on a mission to increase global access to gene therapies Jennifer Adair, along with others, founded the Global Gene Therapy Initiative in 2020, to expand global access to curative gene therapies. By Jason Mast

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Cancer Briefing? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser